Company Encyclopedia
View More
name
REPUBLIC HC
08357.HK
Republic Healthcare Limited, an investment holding company, operates medical clinics under the Dr. Tan & Partners (DTAP) brand in Singapore. It offers consultation, medical investigation, and treatment services; and men and women’s sexual health services. The company is also involved in management consultancy services; online and wholesale trade of goods; wholesale of medical, professional, scientific, and precision equipment; and educational support services.
52.63 B
08357.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking16/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-10.42%D
    • Profit Margin-14.64%D
    • Gross Margin16.29%D
  • Growth ScoreD
    • Revenue YoY-6.14%D
    • Net Profit YoY-75.99%E
    • Total Assets YoY-2.42%D
    • Net Assets YoY-4.14%D
  • Cash ScoreD
    • Cash Flow Margin-683.13%E
    • OCF YoY-6.14%D
  • Operating ScoreB
    • Turnover0.6B
  • Debt ScoreA
    • Gearing Ratio17.16%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    REPUBLIC HC released its interim results, reporting a net loss of SGD 1.2167 million, an increase of 715.78% year-on-year

    According to the Zhitong Finance APP, REPUBLIC HC released its interim results for the six months ending June 30, 2025, reporting revenue of SGD 3.7345 million, a year-on-year decrease of 16.67%; the net loss from continuing operations for the period was SGD 1.2167 million, a year-on-year increase of 715.78%; the loss per share was 0.2 Singapore cents

    Zhitong·
    HK
    08357
    -3.49%
    Zhitong·
    HK
    08357
    -3.49%

    REPUBLIC HC issues profit warning, expects significant increase in mid-term net loss

    REPUBLIC HC issued a profit warning, expecting a significant increase in net losses for the six months ending June 30, 2025, compared to SGD 1.088 million in the same period of 2024. The main reasons include intensified market competition leading to a decline in revenue, economic uncertainty making patients price-sensitive, increased compliance costs due to revisions in medical regulations, and exchange rate fluctuations causing foreign exchange losses. The group's education and expansion business in the Philippines also faces high operating costs

    Zhitong·
    HK
    08357
    -3.49%
    Zhitong·
    HK
    08357
    -3.49%

    REPUBLIC HC plans to invest in Langgu Bio through capital increase and share expansion

    REPUBLIC HC announced that it has signed a letter of intent for an investment agreement with Langgu Bio, planning to invest through capital increase and share expansion. The investment amount and shareholding ratio will be determined in the formal agreement. Langgu Bio's personalized DC vaccine technology has been approved for clinical treatment, marking its transformation into a profitable enterprise. This move will help REPUBLIC HC expand into the Southeast Asian and Greater China markets, enhance investment returns, and create new business opportunities

    Zhitong·
    HK
    08357
    -3.49%
    Zhitong·
    HK
    08357
    -3.49%

    REPUBLIC HC's subsidiary plans to purchase Philippine property for 21.418 million pesos

    REPUBLIC HC announced that its wholly-owned subsidiary Republic Resources Corporation has signed an agreement to purchase a property located in Makati City, Philippines, for PHP 21.418 million from Alveo Land Corporation. The property, which is approximately 80 square meters, is under construction and is planned to be used as the group's office. The property is situated in a commercial center, has long-term investment potential, and the purchase cost is below market price, which is expected to provide financial stability and capital appreciation opportunities

    Zhitong·
    HK
    08357
    -3.49%
    Zhitong·
    HK
    08357
    -3.49%

    REPUBLIC HC released its 2024 annual performance, with a net loss of SGD 178,000, narrowing by 79.2% year-on-year

    REPUBLIC HC released its 2024 annual performance, with revenue of SGD 8.6566 million, a year-on-year decrease of 13.5%; net loss of SGD 178,000, a year-on-year narrowing of 79.2%. The basic loss per share is 0.03 Singapore cents. The decrease in revenue is mainly due to intensified competition and rising costs in core areas such as sexual health, men's health, and women's health, while overall economic pressures affect profitability. The group focuses on operational efficiency and cost management to mitigate financial impacts

    Zhitong·
    HK
    08357
    -3.49%
    Zhitong·
    HK
    08357
    -3.49%
    © 2025 Longbridge｜Disclaimer